🛰️ Daily AI Frontier
‹ back to 2026-07-27

字节加码AI for Science,全网悬赏100位科学家!已孵化一家AI制药

Industry & News Bioinformatics AI

Ranking

Overall 64
Content 70
Popularity N/A

No observed public metrics; popularity remains neutral/archived.

Representative image for 字节加码AI for Science,全网悬赏100位科学家!已孵化一家AI制药

Merged summary

TL;DR - ByteDance Seed launched a six-month program to recruit 100 scientists for AI-for-science collaborations, while expanding its work in computational biology and AI-driven drug discovery. Its efforts have already produced multiple protein and molecular models and an AI-pharma company, Anew Therapeutics.

  • The program targets doctoral-level researchers in mathematics, physics, chemistry, biology, materials, and engineering who actively use AI and preferably can program.
  • Seed has released models including PXDesign, Protenix, SeedProteo, SeedFold, and UniMoMo for protein computation, design, and molecular generation.
  • Anew Therapeutics disclosed a preclinical IL-17 small-molecule inhibitor discovered using AI-based virtual screening and molecular generation.
  • ByteDance is also applying AI to battery research through a joint laboratory with BYD and has explored mathematical reasoning through IMO 2025 participation.

Sources (1)

字节加码AI for Science,全网悬赏100位科学家!已孵化一家AI制药

WeChat: 智药局 2026-07-25
Public signals N/A
Providers: Hugging Face · N/A OpenAlex · N/A Publisher · N/A Semantic Scholar · N/A X · N/A Fetched 2026-08-26 14:45:36.318461 UTC

TL;DR - ByteDance Seed launched a six-month program to recruit 100 scientists for AI-for-science collaborations, while expanding its work in computational biology and AI-driven drug discovery. Its efforts have already produced multiple protein and molecular models and an AI-pharma company, Anew Therapeutics.

  • The program targets doctoral-level researchers in mathematics, physics, chemistry, biology, materials, and engineering who actively use AI and preferably can program.
  • Seed has released models including PXDesign, Protenix, SeedProteo, SeedFold, and UniMoMo for protein computation, design, and molecular generation.
  • Anew Therapeutics disclosed a preclinical IL-17 small-molecule inhibitor discovered using AI-based virtual screening and molecular generation.
  • ByteDance is also applying AI to battery research through a joint laboratory with BYD and has explored mathematical reasoning through IMO 2025 participation.
item →